Industry experts Neil Rotherham, Tim Davis and Jeremy Edwards have been appointed Chairman, Chief Executive Officer and Chief Commercial Officer, respectively.

The new executive team now brings together over 100 years of combined experience in life sciences, particularly focused on patient engagement and mobile technology.

Building on promising foundations established by founders Julie Walters and Peter Coë, the enhanced leadership team has the proven ability to drive innovation in a risk-averse industry.

Tim Davis said: “Raremark is a growing company, with a vision of the future in which all rare diseases are treated. With such strong foundations, I’m excited to build on the innovative platform already in place, creating communities of people affected by a rare condition, sharing knowledge and harnessing the wisdom of the crowd. Patients can play a heroic role in drug development, particularly in rare disease, making the rare real for the next generation.”

Read the full press release here.